Europe Self-monitoring Blood Glucose Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Europe Blood Glucose Monitoring Market Trends and the Market is Segmented by Components (glucometer Devices, Test Strips, And Lancets) and Geography (France, Germany, Italy, Rest of Europe, Russia, Spain, United Kingdom). The Market Provides the Value (in USD) for the Above-Mentioned Segments.

Europe Self-monitoring Blood Glucose Devices Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Europe Self-monitoring Blood Glucose Device Market Size

Europe Self-monitoring Blood Glucose Devices Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 3.34 Billion
Market Size (2030) USD 4.55 Billion
CAGR (2025 - 2030) 6.38 %

Major Players

Europe Self-monitoring Blood Glucose Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Europe Self-monitoring Blood Glucose Devices Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Europe Self-monitoring Blood Glucose Device Market Analysis

The Europe Self-monitoring Blood Glucose Devices Market size is estimated at USD 3.34 billion in 2025, and is expected to reach USD 4.55 billion by 2030, at a CAGR of 6.38% during the forecast period (2025-2030).

European countries are suffering from the burden of high diabetes expenditure due to its rising prevalence. Technological advancements have increased over the period in Diabetes care devices for safer and more accurate measurement of blood glucose levels.

According to the IDF report, about 1 in 11 adults in Europe had diabetes, which accounted for approximately 61 million. These figures indicated that approximately 19.6% of global expenditures were spent on diabetes in Europe. Every year, 21,600 children are added to the type-1 diabetic population pool. The European region has witnessed an alarming increase in the prevalence of diabetes in recent years. Patients with diabetes require many corrections throughout the day for maintaining nominal blood glucose levels, such as oral anti-diabetic medication or the ingestion of additional carbohydrates, by monitoring their blood glucose levels.

According to the German Diabetes Center (DDZ), about 8.5 million people in Germany are affected by diabetes. The number of people with type-2 diabetes in Germany will continue to increase over the next twenty years. Researchers at DDZ estimate that up to 12 million people might suffer from metabolic disorders in 2040.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

Europe Self-monitoring Blood Glucose Device Industry Overview

The European self-monitoring blood glucose devices market is fragmented, with a few major manufacturers having a global market presence and occupying a major share, like Abbott, LifeScan, Roche, Ascensia, etc., while the rest are confined to other local or region-specific manufacturers.

Europe Self-monitoring Blood Glucose Device Market Leaders

  1. Abbott Diabetes Care

  2. Roche Diabetes Care

  3. Arkray Inc.

  4. Ascensia Diabetes Care

  5. Lifescan Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Europe Self-monitoring Blood Glucose Devices Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Europe Self-monitoring Blood Glucose Device Market News

  • January 2023: LifeScan announced that the peer-reviewed Journal of Diabetes Science and Technology published improved glycemic control using a Bluetooth-connected blood glucose meter and a mobile diabetes app: Real-World Evidence from over 144,000 people with diabetes, detailing results from a retrospective analysis of real-world data from over 144,000 people with diabetes-one of the largest combined blood glucose meter and mobile diabetes app datasets ever published.
  • January 2022: Roche launched its new point-of-care blood glucose monitor designed for hospital professionals, with a companion device shaped like a touchscreen smartphone that will run its own apps. The hand-held Cobas pulse includes an automated glucose test strip reader as well as a camera and touchscreen for logging other diagnostic results. It's designed to be used with patients of all ages, including neonates and people in intensive care.

Europe Self-monitoring Blood Glucose Device Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Component
    • 5.1.1 Glucometer Devices
    • 5.1.2 Test Strips
    • 5.1.3 Lancets
  • 5.2 Geography
    • 5.2.1 France
    • 5.2.2 Germany
    • 5.2.3 Italy
    • 5.2.4 Rest of Europe
    • 5.2.5 Russia
    • 5.2.6 Spain
    • 5.2.7 United Kingdom

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes Population
  • 6.2 Type-2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Abbott Diabetes Care
    • 7.1.2 Roche Diabetes Care
    • 7.1.3 LifeScan
    • 7.1.4 Arkray
    • 7.1.5 Ascensia Diabetes Care
    • 7.1.6 Agamatrix
    • 7.1.7 Bionime Corporation
    • 7.1.8 Acon
    • 7.1.9 Medisana
    • 7.1.10 Trivida
    • 7.1.11 Rossmax International
  • *List Not Exhaustive
  • 7.2 Company Share Analysis
    • 7.2.1 Abbott Diabetes Care
    • 7.2.2 LifeScan
    • 7.2.3 Roche Diabetes Care
    • 7.2.4 Other Company Share Analyses

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
*The report covers a segment-wise breakdown (Value and Volume) for all the countries covered under Table of Contents **Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Europe Self-monitoring Blood Glucose Device Industry Segmentation

Self-monitoring of blood glucose is an approach used by diabetic patients to measure their blood sugar level using a glucometer, test strips, and lancets. Based on the readings, patients can adjust or check the effect of their treatment. The European self-monitoring blood glucose device market is segmented into components and geography . The report offers the value (in USD) and volume (in units) for the above segments.

Component Glucometer Devices
Test Strips
Lancets
Geography France
Germany
Italy
Rest of Europe
Russia
Spain
United Kingdom
Need A Different Region or Segment?
Customize Now

Europe Self-monitoring Blood Glucose Device Market Research FAQs

How big is the Europe Self-monitoring Blood Glucose Devices Market?

The Europe Self-monitoring Blood Glucose Devices Market size is expected to reach USD 3.34 billion in 2025 and grow at a CAGR of 6.38% to reach USD 4.55 billion by 2030.

What is the current Europe Self-monitoring Blood Glucose Devices Market size?

In 2025, the Europe Self-monitoring Blood Glucose Devices Market size is expected to reach USD 3.34 billion.

Who are the key players in Europe Self-monitoring Blood Glucose Devices Market?

Abbott Diabetes Care, Roche Diabetes Care, Arkray Inc., Ascensia Diabetes Care and Lifescan Inc. are the major companies operating in the Europe Self-monitoring Blood Glucose Devices Market.

What years does this Europe Self-monitoring Blood Glucose Devices Market cover, and what was the market size in 2024?

In 2024, the Europe Self-monitoring Blood Glucose Devices Market size was estimated at USD 3.13 billion. The report covers the Europe Self-monitoring Blood Glucose Devices Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Europe Self-monitoring Blood Glucose Devices Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Europe Blood Glucose Monitoring Industry Report

Statistics for the 2025 Europe Self-monitoring Blood Glucose Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Europe Self-monitoring Blood Glucose Devices analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.